var data={"title":"Nummular eczema","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Nummular eczema</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/nummular-eczema/contributors\" class=\"contributor contributor_credentials\">Matthew J Zirwas, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/nummular-eczema/contributors\" class=\"contributor contributor_credentials\">Joseph Fowler, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/nummular-eczema/contributors\" class=\"contributor contributor_credentials\">Rosamaria Corona, MD, DSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/nummular-eczema/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 28, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H4813942\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nummular eczema, also called discoid eczema or nummular dermatitis, is a chronic inflammatory skin disease characterized by multiple, pruritic, coin-shaped eczematous lesions involving the extremities and, less commonly, the trunk (<a href=\"image.htm?imageKey=DERM%2F96165\" class=\"graphic graphic_picture graphicRef96165 \">picture 1A</a>) [<a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/1\" class=\"abstract_t\">1</a>]. Nummular eczema is regarded as a distinctive form of endogenous (idiopathic) eczema. </p><p>This topic will discuss the clinical features, diagnosis, and treatment of nummular eczema. Atopic dermatitis, allergic contact dermatitis, and other types of eczematous dermatitis are discussed separately.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=treatment-of-atopic-dermatitis-eczema\" class=\"medical medical_review\">&quot;Treatment of atopic dermatitis (eczema)&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-allergic-contact-dermatitis\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of allergic contact dermatitis&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=irritant-contact-dermatitis-in-adults\" class=\"medical medical_review\">&quot;Irritant contact dermatitis in adults&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=stasis-dermatitis\" class=\"medical medical_review\">&quot;Stasis dermatitis&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=urticarial-dermatitis\" class=\"medical medical_review\">&quot;Urticarial dermatitis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H4813956\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nummular eczema affects men more frequently than women. Most patients are over the age of 50, although individuals of any age can be affected [<a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/2\" class=\"abstract_t\">2</a>]. </p><p class=\"headingAnchor\" id=\"H4813963\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of nummular eczema is incompletely understood. Numerous factors have been implicated as causal, including xerosis and decreased cutaneous lipid production, <em>Staphylococcus</em> <em>aureus</em> colonization, contact allergy to metals, and sensitization to environmental aeroallergens such as <em>Candida albicans</em> or house dust mites [<a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/1,3-8\" class=\"abstract_t\">1,3-8</a>]. Nummular eczema has been reported in patients treated with <a href=\"topic.htm?path=isotretinoin-drug-information\" class=\"drug drug_general\">isotretinoin</a> and in patients with hepatitis C infection treated with interferon-alpha-2b and <a href=\"topic.htm?path=ribavirin-drug-information\" class=\"drug drug_general\">ribavirin</a> [<a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/9-11\" class=\"abstract_t\">9-11</a>]. In a study of 1662 patients undergoing breast reconstruction, approximately 3 percent developed nummular eczema in the area of reconstruction [<a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/12\" class=\"abstract_t\">12</a>]. In nearly two-thirds of cases, nummular eczema developed after the implantation of tissue expanders or silicone implants, suggesting that stretching or tension applied to the skin may be a trigger for this type of dermatitis.</p><p class=\"headingAnchor\" id=\"H63757045\"><span class=\"h1\">PATHOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathologic features of nummular eczema are indistinguishable from other forms of eczema, showing primarily spongiosis, superficial perivascular lymphocytic infiltrates, with some eosinophils and occasional neutrophils and plasma cells (<a href=\"image.htm?imageKey=DERM%2F97004\" class=\"graphic graphic_picture graphicRef97004 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/13\" class=\"abstract_t\">13</a>]. Mild papillary edema and vascular dilation may be present.</p><p class=\"headingAnchor\" id=\"H4813971\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nummular eczema typically presents with highly pruritic, round, coin-shaped patches of eczematous dermatitis ranging in diameter from 1 to 10 cm (<a href=\"image.htm?imageKey=DERM%2F96165%7EDERM%2F96163%7EDERM%2F96164\" class=\"graphic graphic_picture graphicRef96165 graphicRef96163 graphicRef96164 \">picture 1A-C</a>). In the acute phase, lesions are dull red, exudative, and crusted. Over time, they become more dry and scaly, occasionally with central clearing leading to annular lesions. </p><p>The legs and the upper extremities are the sites most frequently involved. Involvement of the trunk is less common, but when present, the lower trunk is more likely to be involved than the upper trunk. If the face or neck is involved, alternative diagnoses should be considered.</p><p>Nummular eczema is a chronic and relapsing disease. Days to months after resolution, apparently dormant lesions may become active again or new lesions may occur in adjacent areas. &#160; </p><p class=\"headingAnchor\" id=\"H4813985\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of nummular eczema is usually clinical, based upon the typical finding of round, coin-shaped, and highly pruritic lesions in a patient with diffusely dry skin. Biopsy or laboratory tests are generally not necessary for diagnosis. However, a skin swab for bacterial culture may be performed in patients with exudative or crusted lesions if infection with unusual organisms is suspected. Patch testing may be helpful in patients with recalcitrant disease <span class=\"nowrap\">and/or</span> a history suggesting allergic contact dermatitis [<a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/6,14\" class=\"abstract_t\">6,14</a>]. (See <a href=\"topic.htm?path=patch-testing\" class=\"medical medical_review\">&quot;Patch testing&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H4813992\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of nummular eczema includes:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Atopic dermatitis</strong> &ndash; Nummular lesions may be an atypical clinical presentation of atopic dermatitis in both adults and children [<a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/15,16\" class=\"abstract_t\">15,16</a>]. A history of atopic disease, including reactions to aeroallergens, asthma, and atopic dermatitis in typical flexural locations supports the diagnosis of atopic dermatitis. (See <a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Allergic contact dermatitis</strong> &ndash; Allergic contact dermatitis may rarely present with lesions indistinguishable from nummular eczema. Comprehensive patch testing to contact sensitizers based upon the patient's history of exposure can clarify the diagnosis. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-allergic-contact-dermatitis\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of allergic contact dermatitis&quot;</a> and <a href=\"topic.htm?path=patch-testing\" class=\"medical medical_review\">&quot;Patch testing&quot;</a>.) &#160;</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Tinea corporis</strong> &ndash; Early lesions of tinea corporis may mimic nummular eczema (<a href=\"image.htm?imageKey=DERM%2F53823%7EPC%2F53271\" class=\"graphic graphic_picture graphicRef53823 graphicRef53271 \">picture 3A-B</a>). A potassium hydroxide (KOH) preparation will show the segmented hyphae and arthrospores characteristic of all dermatophyte infections. (See <a href=\"topic.htm?path=dermatophyte-tinea-infections\" class=\"medical medical_review\">&quot;Dermatophyte (tinea) infections&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Stasis dermatitis</strong> &ndash; Early lesions of stasis dermatitis may present as erythematous, scaly, and itchy patches (<a href=\"image.htm?imageKey=DERM%2F70596\" class=\"graphic graphic_picture graphicRef70596 \">picture 4</a>). A history of venous insufficiency <span class=\"nowrap\">and/or</span> the presence of other signs of chronic venous insufficiency such as varicosities, pitting edema, and hyperpigmentation support the diagnosis of stasis dermatitis. (See <a href=\"topic.htm?path=stasis-dermatitis\" class=\"medical medical_review\">&quot;Stasis dermatitis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Psoriasis</strong> &ndash; Psoriatic lesions are usually dry, with more prominent scaling, and asymptomatic, although some patients may complain of pruritus. (See <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of psoriasis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H4813999\"><span class=\"h1\">MANAGEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The management of nummular eczema involves general measures aimed at reducing skin dryness and exposure to irritants and treatment of skin inflammation. </p><p class=\"headingAnchor\" id=\"H63757414\"><span class=\"h2\">General measures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>General measures to reduce skin dryness and exposure to skin irritants may include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Limit bathing to once daily with lukewarm water using mild, nonsoap cleansers.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Apply a moisturizer at least twice a day and immediately after bathing. The author prefers cream preparations that contain ceramides.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Use a laundry detergent that is based primarily on nonionic surfactants <span class=\"nowrap\">and/or</span> double-rinse the laundry.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Consider oral supplementation with L-histidine. L-histidine has been shown to increase filaggrin levels in keratinocytes and improve xerosis [<a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/17\" class=\"abstract_t\">17</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Consider obtaining a whole house humidifier or a room humidifier for the bedroom.</p><p/><p class=\"headingAnchor\" id=\"H63757426\"><span class=\"h2\">First-line therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>High- or ultra-high potency topical corticosteroids (groups 1 to 3 (<a href=\"image.htm?imageKey=DERM%2F62402\" class=\"graphic graphic_table graphicRef62402 \">table 1</a>)) are first-line therapy for nummular eczema. Topical corticosteroids are applied once or twice daily for two to four weeks or until resolution of the lesions. The use of occlusive dressings may enhance the corticosteroid penetration into the skin and may lead to a more rapid response.&nbsp;</p><p>For isolated recalcitrant lesions, intralesional <a href=\"topic.htm?path=triamcinolone-drug-information\" class=\"drug drug_general\">triamcinolone</a> may be a treatment option. The author injects 0.5 to 1 mL of 4 to 5 <span class=\"nowrap\">mg/mL</span> triamcinolone per lesion. Patients should be warned about the possibility of temporary atrophy or dyspigmentation.</p><p>The efficacy of topical corticosteroids for the treatment of nummular eczema has not been evaluated in randomized trials. Their use is based upon indirect evidence of efficacy in other eczematous skin diseases (eg, atopic dermatitis, allergic contact dermatitis) and clinical experience. &#160;</p><p class=\"headingAnchor\" id=\"H4814013\"><span class=\"h2\">Severe or refractory disease</span></p><p class=\"headingAnchor\" id=\"H77414229\"><span class=\"h3\">Phototherapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with extensive disease that does not respond to topical corticosteroids may be treated with narrowband ultraviolet B (NBUVB) therapy. Typically, 10 to 30 treatments, given two to three times per week, are necessary before a response is noted. Once all lesions are cleared, the frequency may be reduced to once weekly for a month, then to every other week for two months, as needed and tolerated. (See <a href=\"topic.htm?path=uvb-therapy-broadband-and-narrowband\" class=\"medical medical_review\">&quot;UVB therapy (broadband and narrowband)&quot;</a>.)</p><p>If NBUVB therapy is not available or not possible for logistic reasons, commercial tanning beds or natural sunlight during the summer may be alternative options. If natural sunlight is utilized, patients should be instructed to start by obtaining 10 minutes of direct, unprotected sunlight between 10 AM and 2 PM and increasing the duration by several minutes daily, up to a maximum of 30 minutes daily. Lightly pigmented patients and those with red or blond hair may need to start with 5 minutes and limit the exposure time to a maximum of 20 minutes. Unaffected areas of the skin should be covered to limit unnecessary solar exposure.</p><p>The potential increased risk of skin cancer should be weighed against the benefits of avoiding the use of systemic immunosuppressants in the individual patient.</p><p class=\"headingAnchor\" id=\"H77414235\"><span class=\"h3\">Systemic therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For patients with recalcitrant disease, a short course of systemic corticosteroids is an alternative treatment option if phototherapy is not available or not possible for logistic reasons. The author's preference is to use intramuscular <a href=\"topic.htm?path=triamcinolone-drug-information\" class=\"drug drug_general\">triamcinolone</a> at a dose of 40 mg given up to once every three months. For clinicians who prefer oral corticosteroids, <a href=\"topic.htm?path=prednisone-drug-information\" class=\"drug drug_general\">prednisone</a> can be initiated at 40 mg per day, with the dose reduced by 10 mg every 5 days and then discontinued. </p><p><a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">Methotrexate</a> 10 to 25 mg per week or <a href=\"topic.htm?path=cyclosporine-ciclosporin-drug-information\" class=\"drug drug_general\">cyclosporine</a> 3 to 5 <span class=\"nowrap\">mg/kg</span> per day are alternative therapies for patients in whom systemic corticosteroids are contraindicated or in whom the disease recurs shortly after corticosteroid discontinuation. The author initiates methotrexate therapy with 10 mg weekly for six weeks. If the response is inadequate and laboratory monitoring has not shown any abnormalities, the dose is increased to 15 mg weekly for another four to six weeks, and this pattern is continued up to a maximum dosage of 25 mg weekly if needed to achieve clearance. Once an adequate response is achieved, the dose is maintained for three to six months and then tapered by 2.5 mg monthly until the medication is stopped or until the minimum dose necessary for disease control is achieved. </p><p><a href=\"topic.htm?path=cyclosporine-ciclosporin-drug-information\" class=\"drug drug_general\">Cyclosporine</a> is initiated at a dose of 4 <span class=\"nowrap\">mg/kg</span> per day (based upon ideal body weight). This dose is maintained until the disease is controlled, typically two to six weeks. The dose is then reduced by 100 <span class=\"nowrap\">mg/day</span> every one to two months until discontinuation. </p><p>Systemic corticosteroids, <a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">methotrexate</a>, or <a href=\"topic.htm?path=cyclosporine-ciclosporin-drug-information\" class=\"drug drug_general\">cyclosporine</a> for the treatment of nummular eczema have not been evaluated in clinical trials. Their use is based upon evidence of efficacy in the treatment of other forms of severe dermatitis. The use of methotrexate for nummular eczema has been reported in a single observational study of 25 pediatric patients [<a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/18\" class=\"abstract_t\">18</a>]. Complete clearance was observed in 16 children after an average treatment time of 10.5 months.</p><p class=\"headingAnchor\" id=\"H66627254\"><span class=\"h1\">PROGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Prognosis is excellent, with disease control achieved in nearly all patients and eventual long-term remission achieved in the majority.</p><p class=\"headingAnchor\" id=\"H4814035\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nummular eczema, also called discoid eczema, is a chronic inflammatory skin disease characterized by multiple, coin-shaped eczematous lesions (<a href=\"image.htm?imageKey=DERM%2F96165\" class=\"graphic graphic_picture graphicRef96165 \">picture 1A</a>). (See <a href=\"#H4813942\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nummular eczema typically presents with highly pruritic, round, coin-shaped patches of eczematous dermatitis ranging in diameter from 1 to 10 cm (<a href=\"image.htm?imageKey=DERM%2F96163%7EDERM%2F96164\" class=\"graphic graphic_picture graphicRef96163 graphicRef96164 \">picture 1B-C</a>). The legs and the upper extremities are the sites most frequently involved. (See <a href=\"#H4813971\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of nummular eczema is clinical. Patch testing may be helpful in patients with recalcitrant disease <span class=\"nowrap\">and/or</span> a history suggesting allergic contact dermatitis. (See <a href=\"#H4813985\" class=\"local\">'Diagnosis'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>High- or ultra-high potency topical corticosteroids (groups 1 to 3 (<a href=\"image.htm?imageKey=DERM%2F62402\" class=\"graphic graphic_table graphicRef62402 \">table 1</a>)) are the first-line therapy for nummular eczema. Topical corticosteroids are applied twice daily for two to four weeks or until resolution of the lesions. (See <a href=\"#H63757426\" class=\"local\">'First-line therapy'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients with extensive or recalcitrant disease that does not respond to topical corticosteroids, narrowband ultraviolet B (NBUVB) phototherapy or systemic immunosuppressants are alternative treatments. (See <a href=\"#H4814013\" class=\"local\">'Severe or refractory disease'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/1\" class=\"nounderline abstract_t\">Jiamton S, Tangjaturonrusamee C, Kulthanan K. Clinical features and aggravating factors in nummular eczema in Thais. Asian Pac J Allergy Immunol 2013; 31:36.</a></li><li class=\"breakAll\">Susan Burgin. Nummular eczema, lichen simplex chronicus, and prurigo nodularis. In: Fitzpatrick's Dermatology in General Medicine, 8th ed, Goldsmith LA, Katz SI, Gilchrest BA, et al (Eds), McGraw-Hill, 2012. Vol 1, p.182.</li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/3\" class=\"nounderline abstract_t\">Kim WJ, Ko HC, Kim MB, et al. Features of Staphylococcus aureus colonization in patients with nummular eczema. Br J Dermatol 2013; 168:658.</a></li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/4\" class=\"nounderline abstract_t\">Bonamonte D, Foti C, Vestita M, et al. Nummular eczema and contact allergy: a retrospective study. Dermatitis 2012; 23:153.</a></li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/5\" class=\"nounderline abstract_t\">Krupa Shankar DS, Shrestha S. Relevance of patch testing in patients with nummular dermatitis. Indian J Dermatol Venereol Leprol 2005; 71:406.</a></li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/6\" class=\"nounderline abstract_t\">Khurana S, Jain VK, Aggarwal K, Gupta S. Patch testing in discoid eczema. J Dermatol 2002; 29:763.</a></li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/7\" class=\"nounderline abstract_t\">Schena D, Papagrigoraki A, Girolomoni G. Sensitizing potential of triclosan and triclosan-based skin care products in patients with chronic eczema. Dermatol Ther 2008; 21 Suppl 2:S35.</a></li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/8\" class=\"nounderline abstract_t\">Aoyama H, Tanaka M, Hara M, et al. Nummular eczema: An addition of senile xerosis and unique cutaneous reactivities to environmental aeroallergens. Dermatology 1999; 199:135.</a></li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/9\" class=\"nounderline abstract_t\">Bettoli V, Tosti A, Varotti C. Nummular eczema during isotretinoin treatment. J Am Acad Dermatol 1987; 16:617.</a></li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/10\" class=\"nounderline abstract_t\">Shen Y, Pielop J, Hsu S. Generalized nummular eczema secondary to peginterferon Alfa-2b and ribavirin combination therapy for hepatitis C infection. Arch Dermatol 2005; 141:102.</a></li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/11\" class=\"nounderline abstract_t\">Moore MM, Elpern DJ, Carter DJ. Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Arch Dermatol 2004; 140:215.</a></li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/12\" class=\"nounderline abstract_t\">Iwahira Y, Nagasao T, Shimizu Y, et al. Nummular Eczema of Breast: A Potential Dermatologic Complication after Mastectomy and Subsequent Breast Reconstruction. Plast Surg Int 2015; 2015:209458.</a></li><li class=\"breakAll\">Wu H, Branding-Bennett HA, Harrist TJ. Noninfectious vesicobullous and vesicopustular diseases. In: Lever's Histopathology of the skin, 10th Edition, Elder DE (Ed), 2008.</li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/14\" class=\"nounderline abstract_t\">Fleming C, Parry E, Forsyth A, Kemmett D. Patch testing in discoid eczema. Contact Dermatitis 1997; 36:261.</a></li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/15\" class=\"nounderline abstract_t\">Kulthanan K, Samutrapong P, Jiamton S, Tuchinda P. Adult-onset atopic dermatitis: a cross-sectional study of natural history and clinical manifestation. Asian Pac J Allergy Immunol 2007; 25:207.</a></li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/16\" class=\"nounderline abstract_t\">Juli&aacute;n-G&oacute;nzalez RE, Orozco-Covarrubias L, Dur&aacute;n-McKinster C, et al. Less common clinical manifestations of atopic dermatitis: prevalence by age. Pediatr Dermatol 2012; 29:580.</a></li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/17\" class=\"nounderline abstract_t\">Tan SP, Brown SB, Griffiths CE, et al. Feeding filaggrin: effects of l-histidine supplementation in atopic dermatitis. Clin Cosmet Investig Dermatol 2017; 10:403.</a></li><li><a href=\"https://www.uptodate.com/contents/nummular-eczema/abstract/18\" class=\"nounderline abstract_t\">Roberts H, Orchard D. Methotrexate is a safe and effective treatment for paediatric discoid (nummular) eczema: a case series of 25 children. Australas J Dermatol 2010; 51:128.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 13666 Version 4.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H4814035\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H4813942\" id=\"outline-link-H4813942\">INTRODUCTION</a></li><li><a href=\"#H4813956\" id=\"outline-link-H4813956\">EPIDEMIOLOGY</a></li><li><a href=\"#H4813963\" id=\"outline-link-H4813963\">PATHOGENESIS</a></li><li><a href=\"#H63757045\" id=\"outline-link-H63757045\">PATHOLOGY</a></li><li><a href=\"#H4813971\" id=\"outline-link-H4813971\">CLINICAL MANIFESTATIONS</a></li><li><a href=\"#H4813985\" id=\"outline-link-H4813985\">DIAGNOSIS</a><ul><li><a href=\"#H4813992\" id=\"outline-link-H4813992\">Differential diagnosis</a></li></ul></li><li><a href=\"#H4813999\" id=\"outline-link-H4813999\">MANAGEMENT</a><ul><li><a href=\"#H63757414\" id=\"outline-link-H63757414\">General measures</a></li><li><a href=\"#H63757426\" id=\"outline-link-H63757426\">First-line therapy</a></li><li><a href=\"#H4814013\" id=\"outline-link-H4814013\">Severe or refractory disease</a><ul><li><a href=\"#H77414229\" id=\"outline-link-H77414229\">- Phototherapy</a></li><li><a href=\"#H77414235\" id=\"outline-link-H77414235\">- Systemic therapy</a></li></ul></li></ul></li><li><a href=\"#H66627254\" id=\"outline-link-H66627254\">PROGNOSIS</a></li><li><a href=\"#H4814035\" id=\"outline-link-H4814035\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/13666|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/96165\" class=\"graphic graphic_picture\">- Nummular eczema coin</a></li><li><a href=\"image.htm?imageKey=DERM/97004\" class=\"graphic graphic_picture\">- Nummular eczema histo</a></li><li><a href=\"image.htm?imageKey=DERM/96163\" class=\"graphic graphic_picture\">- Nummular eczema</a></li><li><a href=\"image.htm?imageKey=DERM/96164\" class=\"graphic graphic_picture\">- Nummular eczema 2</a></li><li><a href=\"image.htm?imageKey=DERM/53823\" class=\"graphic graphic_picture\">- Tinea corporis leg</a></li><li><a href=\"image.htm?imageKey=PC/53271\" class=\"graphic graphic_picture\">- Tinea corporis on leg</a></li><li><a href=\"image.htm?imageKey=DERM/70596\" class=\"graphic graphic_picture\">- Stasis dermatitis early</a></li></ul></li><li><div id=\"DERM/13666|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/62402\" class=\"graphic graphic_table\">- Topical corticosteroids</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-allergic-contact-dermatitis\" class=\"medical medical_review\">Clinical features and diagnosis of allergic contact dermatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dermatophyte-tinea-infections\" class=\"medical medical_review\">Dermatophyte (tinea) infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis\" class=\"medical medical_review\">Epidemiology, clinical manifestations, and diagnosis of psoriasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=irritant-contact-dermatitis-in-adults\" class=\"medical medical_review\">Irritant contact dermatitis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=patch-testing\" class=\"medical medical_review\">Patch testing</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=stasis-dermatitis\" class=\"medical medical_review\">Stasis dermatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-atopic-dermatitis-eczema\" class=\"medical medical_review\">Treatment of atopic dermatitis (eczema)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=uvb-therapy-broadband-and-narrowband\" class=\"medical medical_review\">UVB therapy (broadband and narrowband)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=urticarial-dermatitis\" class=\"medical medical_review\">Urticarial dermatitis</a></li></ul></div></div>","javascript":null}